Charles S. Eby
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management 7
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism 6
- Hematology top 1%
- Autoimmune and Inflammatory Disorders Research 9
- Blood Coagulation and Thrombosis Mechanisms 8
- Hemophilia Treatment and Research 6
-
- Atrial Fibrillation Management and Outcomes 5
- Biochemistry top 2%
-
- Parvovirus B19 Infection Studies 8
-
- Immune Cell Function and Interaction 7
- Co-authors
- Zaher K. OtrockBrian F. GageHoward L. McLeodAllan E. RettieDeborah A. NickersonDavid K. BloughDavid L. VeenstraMark J. Rieder
- Journals
- Clinical Chemistry (6 papers)Archives of Pathology & Laboratory Medicine (3 papers)Transfusion (2 papers)
- Partner nations
- United StatesItalyNetherlands
In The Last Decade
Charles S. Eby
61 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Internal Medicine 628
- Pharmacology 903
- Hematology 862
- Cardiology and Cardiovascular Medicine 754
- Biochemistry 223
Countries citing papers authored by Charles S. Eby
This map shows the geographic impact of Charles S. Eby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles S. Eby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles S. Eby more than expected).
Fields of papers citing papers by Charles S. Eby
This network shows the impact of papers produced by Charles S. Eby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles S. Eby. The network helps show where Charles S. Eby may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles S. Eby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2019 | 8 | |
| 3 | 2019 | 11 | |
| 4 | 2018 | 19 | |
| 5 | 2017 | 45 | |
| 6 | 2017 | 48 | |
| 7 | 2015 | 31 | |
| 8 | 2013 | 29 | |
| 9 | 2011 | 53 | |
| 10 | 2010 | 70 | |
| 11 | 2008 | 43 | |
| 12 | 2007 | 38 | |
| 13 | 2007 | 2 | |
| 14 | 2005 | 64 | |
| 15 | Effect of VKORC1 Haplotypes on Transcriptional Regulation and Warfarin Dosebreakdown → | 2005 | 988 |
| 16 | 2004 | 30 | |
| 17 | 2003 | 22 | |
| 18 | Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolismbreakdown → | 2003 | 551 |
| 19 | 2002 | 8 | |
| 20 | 2001 | 7 |
About Charles S. Eby
Charles S. Eby is a scholar working on Chemical Health and Safety, Hematology, Internal Medicine, Infectious Diseases and Pharmacology, having authored 61 papers that have together received 3.0k indexed citations. Recurring topics across this work include Autoimmune and Inflammatory Disorders Research (9 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers), Parvovirus B19 Infection Studies (8 papers), Venous Thromboembolism Diagnosis and Management (7 papers), Immune Cell Function and Interaction (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Hemophilia Treatment and Research (6 papers) and Atrial Fibrillation Management and Outcomes (5 papers). The work is most often cited by research in Internal Medicine (628 citations), Pharmacology (903 citations), Hematology (862 citations), Cardiology and Cardiovascular Medicine (754 citations) and Biochemistry (223 citations). Charles S. Eby has collaborated with scholars based in United States, Italy and Netherlands. Frequent co-authors include Zaher K. Otrock, Brian F. Gage, Howard L. McLeod, Allan E. Rettie, Deborah A. Nickerson, David K. Blough, David L. Veenstra, Mark J. Rieder, Alexander P. Reiner and Kenneth E. Thummel. Their work appears in journals such as Clinical Chemistry, Archives of Pathology & Laboratory Medicine, Transfusion, Blood and Blood Cells Molecules and Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.